← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 1998Last known activity
Sep 30, 2025
Timeline
1990s
- Jun 1, 1997
Groupe Cooperateur Multidisciplinaire en Oncologie (GERCOR)— Founded
Drugs by trial phase (45 distinct, 76 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (15 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Anus Neoplasms
- Bile Duct Neoplasms
- Breast Neoplasms
- Carcinoid Tumor
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cholangiocarcinoma
- Colonic Neoplasms
- Colorectal Neoplasms
- Esophageal Neoplasms
- Fallopian Tube Neoplasms
- Gastrointestinal Neoplasms
- Head and Neck Neoplasms
- Liver Neoplasms
- Lung Neoplasms
- Microsatellite Instability
- Neoplasm Metastasis
- Neoplasms
- Neuroendocrine Tumors
- Neurotoxicity Syndromes
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Prostatic Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Stomach Neoplasms
- Thromboembolism
- Urinary Bladder Neoplasms
Recent trials (50)
- NCT07071844Lead sponsorPhase 2Sep 30, 2025
- NCT07028424Lead sponsorPhase 2Jul 31, 2025
- NCT06892054CollaboratorPhase 2Jun 30, 2025
- NCT06646445Lead sponsorPhase 2Dec 31, 2024
- NCT06253611Lead sponsorPhase 2Jul 31, 2024
- NCT06059495Lead sponsorPhase 2Sep 20, 2023
- NCT05528952CollaboratorPhase 2Sep 27, 2022
- NCT05310643Lead sponsorPhase 2May 5, 2022
- NCT04894123Lead sponsorPhase 2Oct 31, 2021
- NCT04730544Lead sponsorPhase 2Apr 1, 2021
- NCT04348045Lead sponsorPhase 2May 31, 2020
- NCT04268121Lead sponsorPhase 2Feb 29, 2020
- NCT04166604Lead sponsorPhase 2Dec 10, 2019
- NCT04006262Lead sponsorPhase 2Jul 15, 2019
- NCT03828227Lead sponsorPhase 3Jun 7, 2019
Details
- Founded
- Paris, FR Jun 1, 1997
- Last known activity
- Sep 30, 2025